06:51 AM EDT, 05/08/2025 (MT Newswires) -- Prestige Consumer Healthcare ( PBH ) reported fiscal Q4 adjusted net income Thursday of $1.32 per diluted share, up from $1.02 a year earlier.

Analysts polled by FactSet expected $1.30.

Revenue for the quarter ended March 31 was $296.5 million, up from $277 million a year earlier.

Analysts surveyed by FactSet expected $291.1 million.

The consumer drug provider said it expects fiscal 2026 diluted EPS of $4.70 to $4.82 on revenue of $1.14 billion to $1.16 billion. Analysts polled by FactSet expect EPS of $4.79 on revenue of $1.16 billion.

Shares of the company were down more than 2.5% in recent premarket activity.